Speciality chemicals well balanced growth driven by life sciences & crop science segments
CRAMS Strong customer traction augurs well
H1FY20/H1FY21
Speciality business
180/199 ,increase 11%
CRAMS 72/133, increase 84%
High value business units 253/332,increase 32% #crams#cdmo
Capacity expansion - High performance product (HPP)
$410 Mn (2800cr) contract signed with global company
$61.5mn(436cr) capex required
Contract period 7yrs,sales will be evenly staggered
Q4fy22 expected commencement of supplies
Project will be executed at Dahej #navinfluorine
High performance product HPP is not part of Navin fluorine existing product portfolio,new set of oppurtunity for application of fluorine in a new vertical
Increase share of high value business, CRAMS & Speciality provide 65 % of topline
Revenue from operations up 12%, 519 cr ,Ebidta 169 cr, PAT 84 cr #COVID19 impacting operations of the company & its clients
Set up the busiest PCR testing center in Bangalore
Overall growth driven by discovery science,R & D center
Significant success for 2 clients
1)Albireo pharma - compound Odevixibat met primary endpoint in phase 3 for children suffering genetic liver disease
Syngene worked on registration batches to phase 3,helping in
regulatory filings
2) C4 therapeutics - biopharmaceutical company, novel therapy for cancer & neurodegenerative disease through Targeted protein degradation, recognized leader ,syngene conducted discovery research projects for C4 over last 3 years #sensex#cdmo
@Mphasis financial result Q2fy21
Established as product challenger - ISG Next Gen Hybrid cloud data services 2020
AWS launch partner for airline,focus on healthcare,trade finance
Major contender as per Everest fr Cloud native Dev services 2020
New partnerships - Snowflake #Nifty
Highest overall QoQ CC organic growth in over a decade
Highest quarterly revenue of $327.4mn ,crosses pre covid peak of Q4'20
Direct business : achieves $1bn annualized run rate
BCM : Consistent track record of double digit YOY growth
QoQ growth 17.4%,best in class #stocks
Insurance: QoQ overall growth 2.5% ,strong pipeline visibility
Broad based & strong growth across verticals in direct business
Europe grew 8.2% YoY in Q2'21 in CC,direct business Europe grew 23% YoY in CC #5G #innovation#AI#cybersecurity#IoT#sensex
#valiantorganic
Speciality chemicals player
Promoters -Hemchand gala(original promoter),now Gogris of Aarti industries
Manufactures & markets Chlorophenols
Facility -fully integrated
Raw material - for Chlorophenol( Chlorine gas & phenol)
Chlorine easily available,phenol import
Industrial use for products in agrochemicals, dyes,pigments,pharma,veterinary,cosmetics
First SME IPO where MF took stake ,Reliance MF
Initially listed on SME platform,got listed on @bse in Sep 20 & @NSEIndia on 5th Oct20
Paying dividends since 2017
In 2017 company merged Abhilasha Tex chemicals into itself
Merger with Amarjyot chemicals expanded product portfolio to dues,pigments,pharma,agrochemicals
Drawbacks - Chinese players,top 10 clients contribute 75% business,sourcing of raw Material 80% from top 10 suppliers
Nikunj dalmia in conversation with Saurabh Mukherjee on @ETNOWlive
@HDFCLIFE - brought big data to their life insurance business
More questionnaire compared to other insurance players
More rigorous health checkups
Better underwriting & embedded value due to big data use
Another player using big data @BajajFinCorp - superior ROE compared to other NBFCs
Move to complete digitization helping IT firms @TCS reorients itself according to need of its fortune 500 clients ,moved from infrastructure software to application development to big data,cloud
@TCS ability to retrain lakhs of employees as per need is a big advantage
Next 3 months economic outlook to remain upbeat as Indis opens up
Small town real estate mkt is picking pace
Strong commentary from @HomeLoansByHDFC guided to strong recovery
Post lockdown pickup
1991 moment for Agriculture
Better pricing power for farmers
Structural reforms in transport & logistics sector to ramp up
India to be the pharma capital of the world
Underownwrship of equities in India #Nifty#sensex#StockMarket
Percentage of corporate profits to GDP low in India
Api & generic companies to have both earnings & PE expansion
India focused pharma companies to have earnings but not PE expansion
Current pharma rally may last longer than previous rally #Nifty#traders#stocks#markets
Electric vehicle adaptation in India will be faster than anticipated
Climate change to drive consumer behavior
Recovery from #COVID19 faster than expected
Oppurtunity in Infra,Hotels sector
Value stocks @ITCCorpCom@TheOfficialSBI to gain in 2nd phase of bull mkt @ETNOWlive